Jenny H. Yeung

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 28, 2026

Preclinical evaluation of lentiviral gene therapy for adenosine deaminase 2 deficiency (DADA2): engraftment efficiency and biodistribution in humanised NBSGW mice.

Preclinical evaluation of lentiviral gene therapy for adenosine deaminase 2 deficiency (DADA2): engraftment efficiency and biodistribution in humanised NBSGW mice.

Journal: Gene therapy

Published: January 20, 2025

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 27, 2023

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

Journal: Blood

Published: March 31, 2023

A prediction model for return to work after injury in Hong Kong: abridged secondary publication.

A prediction model for return to work after injury in Hong Kong: abridged secondary publication.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: December 19, 2022

Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Journal: Medical oncology (Northwood, London, England)

Published: June 07, 2022

Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells.

Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells.

Journal: Cytotherapy

Published: February 02, 2022

A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.

A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.

Journal: Scientific reports

Published: June 26, 2020

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.

Journal: Nature medicine

Published: January 24, 2019

Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.

Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.

Journal: mAbs

Published: February 25, 2016

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging.

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 04, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026